Search Result "hypolipidaemic treatment"
Novel Hypolipidaemic Drugs: Mechanisms of Action and Main Metabolic Effects
Journal: Current Vascular Pharmacology
Volume: 17 Issue: 4 Year: 2019 Page: 332-340
Author(s): Theodosios D. Filippatos,Angelos Liontos,Eliza C. Christopoulou,Moses S. Elisaf
Hypolipidaemic Drug Treatment: Yesterday is Not Gone Yet, Today is Challenging and Tomorrow is Coming Soon; let us Combine them all
Journal: Current Pharmaceutical Design
Volume: 20 Issue: 4 Year: 2014 Page: 6350-6357
Author(s): Vasilios G. Athyros, Konstantinos Tziomalos, Asterios Karagiannis, Dimitri P. Mikhailidis
Diagnosis and Treatment of Dyslipidaemias in Athletes
Journal: Current Vascular Pharmacology
Volume: 15 Issue: 3 Year: 2017 Page: 238-247
Author(s): Georgios A. Christou,Evangelia J. Kouidi,Asterios P. Deligiannis,Dimitrios N. Kiortsis
Rosuvastatin, Pravastatin, and Atorvastatin for the Treatment of Hypercholesterolaemia in HIV-Infected Patients Receiving Protease Inhibitors
Journal: Current HIV Research
Volume: 6 Issue: 6 Year: 2008 Page: 572-578
Author(s): Leonardo Calza, Roberto Manfredi, Vincenzo Colangeli, Daria Pocaterra, Michele Pavoni, Francesco Chiodo
Editorial [Hot topic: Current Topics on Hypolipidaemic Therapy and Cardiovascular Risk Assessment (Guest Editors: Evangelos C. Rizos and Moses S. Elisaf)]
Journal: Current Vascular Pharmacology
Volume: 8 Issue: 5 Year: 2010 Page: 587-588
Author(s): Evangelos C. Rizos, Moses S. Elisaf
Pharmacogenetics and Statin Treatment: Reality or Theory?
Journal: Current Vascular Pharmacology
Volume: 13 Issue: 5 Year: 2015 Page: 616-623
Author(s): Eleni Bousoula, Vana Kolovou, Despoina Perrea, Genovefa Kolovou
Ayurvedic Herbal Therapies: A Review of Treatment and Management ofDementia
Journal: Current Alzheimer Research
Volume: 19 Issue: 8 Year: 2022 Page: 568-584
Author(s): Bikash Kumar Mishra
Heart Score Estimation by Specialized Nurses in a Greek Urban Population
Journal: Current Vascular Pharmacology
Volume: 15 Issue: 1 Year: 2017 Page: 84-90
Author(s): Evaggelia Papadopoulou,Maria Meidani,Maria Boutsikou,Pinelopi Papaspiropoulou,Theodosia Kelaiditou,Afedia Koukouzli,Anastasia Tapola,Ioanna Voudoufianaki,Sophie Mavrogeni,Niki Katsiki,Genovefa Kolovou,Ioannis Lekakis
The Role of PCSK9 in the Pathogenesis of Non-alcoholic Fatty Liver Disease and the Effect of PCSK9 Inhibitors
Journal: Current Pharmaceutical Design
Volume: 24 Issue: 31 Year: 2018 Page: 3654-3657
Author(s): Eleni Theocharidou,Marianna Papademetriou,Andromachi Reklou,Alexandros Sachinidis,Chrisoula Boutari,Olga Giouleme
The Effect of Proprotein Convertase Subtilisin-Kexin Type 9 and its Inhibition on Glucose Metabolism and Cardiovascular Risk. We Should do Better the Second Time After Statins
Journal: Current Pharmaceutical Design
Volume: 23 Issue: 10 Year: 2017 Page: 1477-1483
Author(s): Vasilios G. Athyros,Konstantinos Tziomalos,Michael Doumas,George Sfikas,Asterios Karagiannis